Literature DB >> 1917397

Parapapillary atrophy and retinal vessel diameter in nonglaucomatous optic nerve damage.

J B Jonas1, M C Fernández, G O Naumann.   

Abstract

Parapapillary chorioretinal atrophy and decreased retinal vessel diameter occur in glaucomatous eyes. To evaluate the frequency and degree of these signs in nonglaucomatous optic neuropathy, the authors evaluated morphometrically and compared 47 patients with nonglaucomatous optic nerve atrophy from extraocular causes with 292 patients with primary open-angle glaucoma and 179 normal subjects. Eyes with anterior ischemic optic neuropathy were excluded. The parapapillary atrophy was differentiated into a central zone (beta) with sclera and large choroidal vessels visible by ophthalmoscopy and a peripheral zone (alpha) with irregular pigmentation. Both zones did not differ significantly in the eyes with nonglaucomatous optic neuropathy and the normal eyes. In the glaucomatous eyes, they were significantly larger and occurred more frequently. The retinal vessel diameter was significantly smaller in both groups with optic nerve atrophy than in the normal group. It was concluded that decreased retinal vessel diameters unspecifically suggest optic nerve atrophy. Evaluation of parapapillary chorioretinal atrophy can be helpful in differentiating nonglaucomatous from glaucomatous optic neuropathy.

Entities:  

Mesh:

Year:  1991        PMID: 1917397

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  31 in total

1.  Optic disc morphology in south India: the Vellore Eye Study.

Authors:  J B Jonas; R Thomas; R George; E Berenshtein; J Muliyil
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

Review 2.  A framework for comparing structural and functional measures of glaucomatous damage.

Authors:  Donald C Hood; Randy H Kardon
Journal:  Prog Retin Eye Res       Date:  2007-08-21       Impact factor: 21.198

3.  The role of lipid dysregulation and vascular risk factors in glaucomatous retrobulbar circulation.

Authors:  Monika Modrzejewska; Wilhelm Grzesiak; Daniel Zaborski; Anna Modrzejewska
Journal:  Bosn J Basic Med Sci       Date:  2015-03-15       Impact factor: 3.363

4.  [Effect of intraocular pressure on glaucomatous damage to the optic nerve].

Authors:  J B Jonas; D Yang; N Wang
Journal:  Ophthalmologe       Date:  2014-02       Impact factor: 1.059

5.  Visibility of the normal retinal nerve fiber layer correlated with rim width and vessel caliber.

Authors:  J B Jonas; D Schiro
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-04       Impact factor: 3.117

6.  Follow up of focal narrowing of retinal arterioles in glaucoma.

Authors:  K I Papastathopoulos; J B Jonas
Journal:  Br J Ophthalmol       Date:  1999-03       Impact factor: 4.638

7.  Retinal nerve fiber layer assessment: area versus thickness measurements from elliptical scans centered on the optic nerve.

Authors:  Nimesh B Patel; Xunda Luo; Joe L Wheat; Ronald S Harwerth
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-16       Impact factor: 4.799

8.  Hypodense regions (holes) in the retinal nerve fiber layer in frequency-domain OCT scans of glaucoma patients and suspects.

Authors:  Daiyan Xin; Christine L Talamini; Ali S Raza; Carlos Gustavo V de Moraes; Vivienne C Greenstein; Jeffrey M Liebmann; Robert Ritch; Donald C Hood
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-09       Impact factor: 4.799

9.  Blood vessel contributions to retinal nerve fiber layer thickness profiles measured with optical coherence tomography.

Authors:  Donald C Hood; Brad Fortune; Stella N Arthur; Danli Xing; Jennifer A Salant; Robert Ritch; Jeffrey M Liebmann
Journal:  J Glaucoma       Date:  2008 Oct-Nov       Impact factor: 2.503

10.  Three-dimensional histomorphometry of the normal and early glaucomatous monkey optic nerve head: neural canal and subarachnoid space architecture.

Authors:  J Crawford Downs; Hongli Yang; Christopher Girkin; Lisandro Sakata; Anthony Bellezza; Hilary Thompson; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.